Anthony Howell

62.1k total citations · 10 hit papers
684 papers, 42.9k citations indexed

About

Anthony Howell is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Anthony Howell has authored 684 papers receiving a total of 42.9k indexed citations (citations by other indexed papers that have themselves been cited), including 362 papers in Oncology, 317 papers in Genetics and 230 papers in Cancer Research. Recurrent topics in Anthony Howell's work include Estrogen and related hormone effects (184 papers), Breast Cancer Treatment Studies (137 papers) and BRCA gene mutations in cancer (122 papers). Anthony Howell is often cited by papers focused on Estrogen and related hormone effects (184 papers), Breast Cancer Treatment Studies (137 papers) and BRCA gene mutations in cancer (122 papers). Anthony Howell collaborates with scholars based in United Kingdom, United States and Canada. Anthony Howell's co-authors include Jack Cuzick, Michael P. Lisanti, Federica Sotgia, Ubaldo Martinez‐Outschoorn, D. Gareth Evans, Mitch Dowsett, John Forbes, Richard G. Pestell, Michelle Harvie and Robert B. Clarke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Anthony Howell

662 papers receiving 41.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

2005 1.7k citations Anthony Howell, Jack Cuzick et al. profile →
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

2010 1.1k citations Jack Cuzick, Ivana Šestak et al. profile →
Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

2002 676 citations Anthony Howell, John R. Mackey et al. profile →
Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma

2003 657 citations Anthony Howell, John R. Mackey et al. profile →
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women

2010 577 citations Michelle Harvie, Mary Pegington et al. profile →
Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study

2010 546 citations Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology profile →
Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

2011 540 citations Jack Cuzick, Mitch Dowsett et al. Journal of Clinical Oncology profile →
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial

2002 533 citations Michael Baum, Anthony Howell et al. profile →
Dissociation between steroid receptor expression and cell proliferation in the human breast.

1997 514 citations Robert B. Clarke, Anthony Howell et al. profile →
Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease

2015 383 citations Anthony Howell et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Anthony Howell	21.3k	15.1k	14.7k	12.4k	6.6k	684	42.9k
R. Charles Coombes	13.6k 0.6×	9.1k 0.6×	8.8k 0.6×	13.6k 1.1×	4.4k 0.7×	614	33.0k
Clifford A. Hudis	23.6k 1.1×	14.1k 0.9×	5.8k 0.4×	8.2k 0.7×	6.9k 1.0×	509	39.7k
Nancy E. Davidson	20.5k 1.0×	12.3k 0.8×	7.8k 0.5×	17.6k 1.4×	5.7k 0.9×	398	41.0k
William McGuire	15.8k 0.7×	7.9k 0.5×	11.3k 0.8×	12.5k 1.0×	6.2k 0.9×	472	41.7k
Douglas F. Easton	8.8k 0.4×	8.0k 0.5×	16.9k 1.2×	12.8k 1.0×	3.4k 0.5×	358	33.9k
Michael Gnant	13.1k 0.6×	10.0k 0.7×	5.0k 0.3×	7.8k 0.6×	5.6k 0.8×	555	37.9k
Larry Norton	29.6k 1.4×	16.0k 1.1×	8.4k 0.6×	13.7k 1.1×	8.0k 1.2×	532	50.7k
Scott M. Lippman	12.8k 0.6×	7.9k 0.5×	4.3k 0.3×	13.5k 1.1×	10.6k 1.6×	528	37.2k
Kari Hemminki	10.1k 0.5×	9.0k 0.6×	4.6k 0.3×	12.3k 1.0×	4.3k 0.7×	1.0k	35.2k
Eric P. Winer	36.8k 1.7×	20.2k 1.3×	6.8k 0.5×	10.7k 0.9×	14.4k 2.2×	737	56.6k

Countries citing papers authored by Anthony Howell

Since Specialization

Citations

This map shows the geographic impact of Anthony Howell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Howell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Howell more than expected).

Fields of papers citing papers by Anthony Howell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Howell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Howell. The network helps show where Anthony Howell may publish in the future.

Co-authorship network of co-authors of Anthony Howell

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Howell. A scholar is included among the top collaborators of Anthony Howell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Howell. Anthony Howell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harvie, Michelle, Mary Pegington, Anthony Howell, et al.. (2025). Randomised phase-2 screening trial of intermittent energy restriction plus resistance exercise versus resistance exercise alone during chemotherapy for advanced breast cancer. British Journal of Cancer. 133(7). 1010–1019.

Woof, Victoria G., Anthony Howell, Lynne Fox, et al.. (2024). Are Women’s Breast Cancer Risk Appraisals in Line with Updated Clinical Risk Estimates Communicated? Results from a UK Family History Risk and Prevention Clinic. Cancer Epidemiology Biomarkers & Prevention. 33(12). 1671–1677. 1 indexed citations

Woof, Victoria G., Lorna McWilliams, Anthony Howell, D. Gareth Evans, & David French. (2023). How do women at increased risk of breast cancer make sense of their risk? An interpretative phenomenological analysis. British Journal of Health Psychology. 28(4). 1169–1184. 4 indexed citations

Harvie, Michelle, David French, Mary Pegington, et al.. (2023). Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic. British Journal of Cancer. 128(9). 1690–1700. 4 indexed citations

Bowers, Laura W., Meghana G. Shamsunder, Emily L. Rossi, et al.. (2022). Reversing the Genomic, Epigenetic, and Triple-Negative Breast Cancer–Enhancing Effects of Obesity. Cancer Prevention Research. 15(9). 581–594. 16 indexed citations

Pegington, Mary, Alan Davies, Julia Mueller, et al.. (2022). Evaluating the Acceptance and Usability of an App Promoting Weight Gain Prevention and Healthy Behaviors Among Young Women With a Family History of Breast Cancer: Protocol for an Observational Study. JMIR Research Protocols. 11(12). e41246–e41246. 1 indexed citations

Woof, Victoria G., Anthony Howell, Lorna McWilliams, D. Gareth Evans, & David French. (2022). How do women who are informed that they are at increased risk of breast cancer appraise their risk? A systematic review of qualitative research. British Journal of Cancer. 127(11). 1916–1924. 8 indexed citations

Harvie, Michelle, Suzanne Krizak, Katharine Sellers, et al.. (2022). Prevention Of Breast and Endometrial cancer using Total Diet Replacement (PROBE-TDR) trial: protocol for a randomised controlled trial. BMJ Open. 12(7). e057161–e057161. 1 indexed citations

Harvie, Michelle, Mary Pegington, Sacha J. Howell, et al.. (2021). Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer. British Journal of Cancer. 126(8). 1157–1167. 18 indexed citations

10.

Donnelly, Louise S., Rachel Shaw, Mary Pegington, et al.. (2018). ‘For me it's about not feeling like I'm on a diet’: a thematic analysis of women's experiences of an intermittent energy restricted diet to reduce breast cancer risk. Journal of Human Nutrition and Dietetics. 31(6). 773–780. 9 indexed citations

11.

Smith, Samuel G., Ivana Šestak, Anthony Howell, John Forbes, & Jack Cuzick. (2017). Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I). Journal of Clinical Oncology. 35(23). 2666–2673. 31 indexed citations

12.

Howell, Anthony, Linda Ashcroft, Lesley Fallowfield, et al.. (2017). RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(1). 58–66. 4 indexed citations

13.

Harvie, Michelle & Anthony Howell. (2016). Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence. Advances in Nutrition. 7(4). 690–705. 39 indexed citations

14.

Evans, D. Gareth, Adam R. Brentnall, Michelle Harvie, et al.. (2014). Breast Cancer Risk in Young Women in the National Breast Screening Programme: Implications for Applying NICE Guidelines for Additional Screening and Chemoprevention. Cancer Prevention Research. 7(10). 993–1001. 32 indexed citations

15.

Evans, D. Gareth, Jane Warwick, Susan Astley, et al.. (2012). Assessing Individual Breast Cancer Risk within the U.K. National Health Service Breast Screening Program: A New Paradigm for Cancer Prevention. Cancer Prevention Research. 5(7). 943–951. 93 indexed citations

16.

Ring, Alistair, Ivana Šestak, Michael Baum, et al.. (2011). Influence of Comorbidities and Age on Risk of Death Without Recurrence: A Retrospective Analysis of the Arimidex, Tamoxifen Alone or in Combination Trial. Journal of Clinical Oncology. 29(32). 4266–4272. 50 indexed citations

17.

Ong, Kai Ren, Andrew H. Sims, Michelle Harvie, et al.. (2009). Biomarkers of Dietary Energy Restriction in Women at Increased Risk of Breast Cancer. Cancer Prevention Research. 2(8). 720–731. 39 indexed citations

18.

Eastell, Richard, Judith E. Adams, Robert E. Coleman, et al.. (2008). Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230. Journal of Clinical Oncology. 26(7). 1051–1057. 306 indexed citations

19.

Howell, Anthony, et al.. (2006). The Screening of Women Aged Less Than 50 Years At Increased Risk of Breast Cancer By Virtue of Their Family History.. Research Explorer (The University of Manchester). 3 indexed citations

20.

Wilson, George D., KL Woods, & Anthony Howell. (1979). The effect of prolactin and other hormones on lactalbumin production by normal and neoplastic human breast tissue. Research Explorer (The University of Manchester). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact